WallStreetZenWallStreetZen

NASDAQ: IMUX
Immunic Inc Stock Forecast, Predictions & Price Target

Analyst price target for IMUX

Based on 1 analyst offering 12 month price targets for Immunic Inc.
Min Forecast
$7.00+400%
Avg Forecast
$7.00+400%
Max Forecast
$7.00+400%

Should I buy or sell IMUX stock?

Based on 1 analyst offering ratings for Immunic Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IMUX stock forecasts and price targets.

IMUX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-10-10

1 of 1

Forecast return on equity

Is IMUX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.49%

Forecast return on assets

Is IMUX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

IMUX revenue forecast

What is IMUX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$699.9M
Avg 2 year Forecast
$1.1B
Avg 3 year Forecast
$511.7M

IMUX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMUX$1.40$7.00+400.00%Buy
ATOS$1.00$4.50+350.00%Strong Buy
NGM$1.53$2.53+65.03%Buy
CTXR$0.79$4.00+408.91%Buy
CRBP$28.00$51.00+82.14%Buy

Immunic Stock Forecast FAQ

Is Immunic Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IMUX) stock is to Buy IMUX stock.

Out of 1 analyst, 0 (0%) are recommending IMUX as a Strong Buy, 1 (100%) are recommending IMUX as a Buy, 0 (0%) are recommending IMUX as a Hold, 0 (0%) are recommending IMUX as a Sell, and 0 (0%) are recommending IMUX as a Strong Sell.

If you're new to stock investing, here's how to buy Immunic stock.

What is IMUX's revenue growth forecast for 2026-2028?

(NASDAQ: IMUX) Immunic's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 53.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.07%.

Immunic's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast IMUX's revenue for 2026 to be $62,944,016,169, with the lowest IMUX revenue forecast at $62,944,016,169, and the highest IMUX revenue forecast at $62,944,016,169. On average, 1 Wall Street analysts forecast IMUX's revenue for 2027 to be $94,801,370,087, with the lowest IMUX revenue forecast at $94,801,370,087, and the highest IMUX revenue forecast at $94,801,370,087.

In 2028, IMUX is forecast to generate $46,018,476,068 in revenue, with the lowest revenue forecast at $4,073,784,425 and the highest revenue forecast at $127,787,333,156.

What is IMUX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IMUX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is IMUX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IMUX price target, the average IMUX price target is $7.00, with the highest IMUX stock price forecast at $7.00 and the lowest IMUX stock price forecast at $7.00.

The Wall Street analyst predicted that Immunic's share price could reach $7.00 by Oct 10, 2024. The average Immunic stock price prediction forecasts a potential upside of 400% from the current IMUX share price of $1.40.

What is IMUX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IMUX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.